Responsiveness of the electronic touch screen WOMAC 3.1 OA Index in a short term clinical trial with rofecoxib

Osteoarthritis and Cartilage

Volumn 12, Issue 11, 2004, Pages 912-916

  Theiler, Robert ^a   Bischoff Ferrari, H A ^b   Good, M ^c   Bellamy, N ^d  

^a Stadtspital Triemli   (Switzerland)

^b Division of Rheumatology   (United States)

^c Target BioScience Ltd   (Switzerland)

^d UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Electronic data capturing (EDC); Electronic WOMAC 3.1; Patient self assessment; QUALITOUCH method; Rofecoxib

Indexed keywords

ROFECOXIB;

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; AUTOMATION; CLINICAL TRIAL; COMPUTER PROGRAM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG MONITORING; FEMALE; HIP OSTEOARTHRITIS; HUMAN; INFORMATION PROCESSING; INTERMETHOD COMPARISON; JOINT FUNCTION; JOINT STIFFNESS; KNEE OSTEOARTHRITIS; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OPEN STUDY; OUTPATIENT CARE; PAIN; PRIORITY JOURNAL; QUESTIONNAIRE; SELF EVALUATION; STATISTICAL SIGNIFICANCE; VALIDATION PROCESS;

AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; COMPUTER TERMINALS; FEMALE; HIP JOINT; HUMANS; KNEE JOINT; LACTONES; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; OSTEOARTHRITIS; OSTEOARTHRITIS, HIP; OSTEOARTHRITIS, KNEE; PAIN MEASUREMENT; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; SULFONES; TREATMENT OUTCOME;

EID: 7744245800     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joca.2004.08.006     Document Type: Article

References (11)

1. N. Bellamy W.W. Buchanan A preliminary evaluation of the dimensionality and clinical importance of pain and disability in osteoarthritis of the hip and knee Clin Rheumatol 5 2 1986 231-241
2. N. Bellamy W.W. Buchanan C.H. Goldsmith J. Campbell L.W. Stitt Validation study of WOMAC: A health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee J Rheumatol 15 12 1988 1833-1840
3. N. Bellamy J. Kirwan M. Boers P. Brooks V. Strand P. Tugwell et al. Recommendations for a core set of outcome measures for future phase III clinical trials in knee, hip, and hand osteoarthritis. Consensus development at OMERACT III J Rheumatol 24 4 1997 799-802
4. T. Pincus T. Sokka Quantitative measures for assessing rheumatoid arthritis in clinical trials and clinical care Best Pract Res Clin Rheumatol 17 5 2003 753-781
5. R. Theiler H.A. Bischoff M. Good D. Uebelhart Rofecoxib improves quality of life in patients with hip or knee osteoarthritis Swiss Med Wkly 132 39-40 2002 566-573
6. R. Theiler J. Spielberger H.A. Bischoff N. Bellamy J. Huber S. Kroesen Clinical evaluation of the WOMAC 3.0 OA Index in numeric rating scale format using a computerized touch screen version Osteoarthritis Cartilage 10 6 2002 479-481
7. H.A. Bischoff-Ferrari M. VonDechend N. Bellamy R. Theiler Validation and patient acceptance of a computer touch screen version of the WOMAC 3.1 Osteoarthritis Index Ann Rheum Dis July 1 2004 PMID:15231508
8. G. Stucki D. Meier S. Stucki B.A. Michel A.G. Tyndall W. Dick et al. [Evaluation of a German version of WOMAC (Western Ontario and McMaster Universities) Arthrosis Index] Z Rheumatol 55 1 1996 40-49
9. Bellamy N. Personal communication of the German version of the WOMAC 3.1 with Likert scale
10. A.S. Wilson G.D. Kitas D.M. Carruthers C. Reay J. Skan S. Harris et al. Computerized information-gathering in specialist rheumatology clinics: an initial evaluation of an electronic version of the Short Form 36 Rheumatology (Oxford) 41 3 2002 268-273
11. J. Cohen Statistical Power Analysis for the Behavioral Sciences 2nd edn. 1988 L. Erlbaum Associates Hillsdale, NJ p. xxi, 567